![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 26, 2015 7:30:38 AM
The United States market represents over 1.3 million practitioners with the ability to purchase the TLC-2000 Therapeutic Medical Laser System for their clinical practices.
David Smith, Director of Global Sales stated, “The FDA approval of the TLC-2000 represents a watershed moment for the Company to dramatically increase its customer base in the US and significantly increase corporate revenue through the sale of the safest and most effective therapeutic laser system ever designed to the largest consumer market in the world. I look forward to building the high performing team that will ultimately lead to these significant revenues for Theralase in 2016 and beyond.”
Roger Dumoulin-White, President and CEO, Theralase stated that, "Theralase has now gained access to the largest consumer market in the world with a technology that is far superior to competitive products in safety, but more importantly in efficacy. I look forward to welcoming the world to the next generation of therapeutic laser technology. The United States remains the largest medical device market in the world with a market size of approximately $110 billion, expected to reach $133 billion by 2016."
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM